TBAJ-876 displays bedaquiline-like mycobactericidal potency without retaining the parental drug’s uncoupler activity
The diarylquinoline F1FO-ATP synthase inhibitor bedaquiline (BDQ) displays protonophore activity. Thus, uncoupling electron transport from ATP synthesis appears to be a second mechanism of action of this antimycobacterial drug. Here, we show that the new BDQ analogue TBAJ-876 did not retain the pare...
Saved in:
Main Authors: | Sarathy, Jickky Palmae, Ragunathan, Priya, Cooper, Christopher B., Upton, Anna M., Grüber, Gerhard, Dick, Thomas |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/138548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
MECHANISM OF ACTION OF THE ANTI-TUBERCULOSIS DRUG CANDIDATE TBAJ-876
by: JICKKY PALMAE SARATHY
Published: (2020) -
Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
by: Krah, Alexander, et al.
Published: (2022) -
Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
by: Sarathy, J.P., et al.
Published: (2021) -
TBAJ-876 retains bedaquiline’s activity against subunits c and ε of mycobacterium tuberculosis F-ATP synthase
by: Sarathy, Jickky Palmae, et al.
Published: (2020) -
Re-understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline
by: Sarathy, Jickky Palmae, et al.
Published: (2020)